aluates Reports

$ 0.0

Automative

Global Molecular Pharming Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-16I14494

Global Molecular Pharming Market Research Report 2023

BUY CHAPTERS

Global Molecular Pharming Market Research Report 2025

Code: QYRE-Auto-16I14494

Report

April 2025

Pages:93

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Medicago

Miruku

Mozza

Nobell Foods

Agrenvec

Bright Biotech

Diamante

ORF Genetics

Pfizer Inc

Protalix BioTherapeutics, Inc.

Tiamat Sciences

Meristem Therapeutics S.A. (Ventria Bioscience)

Moolec Science Limited

Core Biogenesis

Leaf Systems International Limited

ProdiGene Inc

Molecular Pharming Market

The global market for Molecular Pharming was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Molecular pharming, also known as biopharming, is a technology that involves the use of genetically modified plants to produce pharmaceuticals or industrial chemicals. This approach relies on the ability of plants to serve as bioreactors for the production of proteins and other complex molecules.

To produce a desired protein, the gene encoding the protein is first inserted into the plant genome. The plant is then grown under controlled conditions, and the protein is harvested from the plant tissue. The protein can then be purified and used for a variety of applications, including drug development, vaccines, and enzyme replacement therapies.

Molecular pharming has several advantages over traditional methods of protein production. Plants are relatively easy to grow and require minimal processing, which can result in lower production costs. Additionally, plant-based production systems are considered to be safer than those that use animal cells or bacteria, as plants are less likely to transmit viruses or other contaminants.

Despite its potential benefits, molecular pharming also has some limitations and challenges. One of the main challenges is ensuring that the plant-produced proteins are properly folded and functional, which can be influenced by factors such as post-translational modifications, environmental conditions, and the choice of plant species. Additionally, there are regulatory and ethical considerations associated with using genetically modified plants for pharmaceutical production.

North American market for Molecular Pharming is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Molecular Pharming is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Molecular Pharming in Recombinant Antibodies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Molecular Pharming include Medicago Inc, Meristem Therapeutics S.A. (Ventria Bioscience), Miruku, Moolec Science Limited, mozza, Nobell Foods, Agrenvec S.L, Bright Biotech, Core Biogenesis, Diamante SRL, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Molecular Pharming, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Pharming.

The Molecular Pharming market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Molecular Pharming market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Molecular Pharming companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Molecular Pharming Market Report

Report Metric	Details
Report Name	Molecular Pharming Market
Segment by Type	Gene Gun Agroinfiltration Electroporation Agrobacterium-Mediated Gene Transfer
Segment by Application	Recombinant Antibodies Hormones, Vaccines Industrial Enzymes Proteins & Protein-Based Materials Technical Reagents Nutritional Products
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Medicago Inc, Meristem Therapeutics S.A. (Ventria Bioscience), Miruku, Moolec Science Limited, mozza, Nobell Foods, Agrenvec S.L, Bright Biotech, Core Biogenesis, Diamante SRL, Leaf Systems International Limited, ORF Genetics, Pfizer, Inc., ProdiGene Inc, Protalix Biotherapeutics, Inc, Tiamat Sciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Pharming company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Molecular Pharming Market report?

Ans: The main players in the Molecular Pharming Market are Medicago Inc, Meristem Therapeutics S.A. (Ventria Bioscience), Miruku, Moolec Science Limited, mozza, Nobell Foods, Agrenvec S.L, Bright Biotech, Core Biogenesis, Diamante SRL, Leaf Systems International Limited, ORF Genetics, Pfizer, Inc., ProdiGene Inc, Protalix Biotherapeutics, Inc, Tiamat Sciences

What are the Application segmentation covered in the Molecular Pharming Market report?

Ans: The Applications covered in the Molecular Pharming Market report are Recombinant Antibodies, Hormones, Vaccines, Industrial Enzymes, Proteins & Protein-Based Materials, Technical Reagents, Nutritional Products

What are the Type segmentation covered in the Molecular Pharming Market report?

Ans: The Types covered in the Molecular Pharming Market report are Gene Gun, Agroinfiltration, Electroporation, Agrobacterium-Mediated Gene Transfer

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Molecular Pharming Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Gene Gun

1.2.3 Agroinfiltration

1.2.4 Electroporation

1.2.5 Agrobacterium-Mediated Gene Transfer

1.3 Market by Application

1.3.1 Global Molecular Pharming Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Recombinant Antibodies

1.3.3 Hormones, Vaccines

1.3.4 Industrial Enzymes

1.3.5 Proteins & Protein-Based Materials

1.3.6 Technical Reagents

1.3.7 Nutritional Products

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Molecular Pharming Market Perspective (2020-2031)

2.2 Global Molecular Pharming Growth Trends by Region

2.2.1 Global Molecular Pharming Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Molecular Pharming Historic Market Size by Region (2020-2025)

2.2.3 Molecular Pharming Forecasted Market Size by Region (2026-2031)

2.3 Molecular Pharming Market Dynamics

2.3.1 Molecular Pharming Industry Trends

2.3.2 Molecular Pharming Market Drivers

2.3.3 Molecular Pharming Market Challenges

2.3.4 Molecular Pharming Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Molecular Pharming Players by Revenue

3.1.1 Global Top Molecular Pharming Players by Revenue (2020-2025)

3.1.2 Global Molecular Pharming Revenue Market Share by Players (2020-2025)

3.2 Global Molecular Pharming Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Molecular Pharming Revenue

3.4 Global Molecular Pharming Market Concentration Ratio

3.4.1 Global Molecular Pharming Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Molecular Pharming Revenue in 2024

3.5 Global Key Players of Molecular Pharming Head office and Area Served

3.6 Global Key Players of Molecular Pharming, Product and Application

3.7 Global Key Players of Molecular Pharming, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Molecular Pharming Breakdown Data by Type

4.1 Global Molecular Pharming Historic Market Size by Type (2020-2025)

4.2 Global Molecular Pharming Forecasted Market Size by Type (2026-2031)

5 Molecular Pharming Breakdown Data by Application

5.1 Global Molecular Pharming Historic Market Size by Application (2020-2025)

5.2 Global Molecular Pharming Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Molecular Pharming Market Size (2020-2031)

6.2 North America Molecular Pharming Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Molecular Pharming Market Size by Country (2020-2025)

6.4 North America Molecular Pharming Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Molecular Pharming Market Size (2020-2031)

7.2 Europe Molecular Pharming Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Molecular Pharming Market Size by Country (2020-2025)

7.4 Europe Molecular Pharming Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Molecular Pharming Market Size (2020-2031)

8.2 Asia-Pacific Molecular Pharming Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Molecular Pharming Market Size by Region (2020-2025)

8.4 Asia-Pacific Molecular Pharming Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Molecular Pharming Market Size (2020-2031)

9.2 Latin America Molecular Pharming Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Molecular Pharming Market Size by Country (2020-2025)

9.4 Latin America Molecular Pharming Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Molecular Pharming Market Size (2020-2031)

10.2 Middle East & Africa Molecular Pharming Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Molecular Pharming Market Size by Country (2020-2025)

10.4 Middle East & Africa Molecular Pharming Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Medicago Inc

11.1.1 Medicago Inc Company Details

11.1.2 Medicago Inc Business Overview

11.1.3 Medicago Inc Molecular Pharming Introduction

11.1.4 Medicago Inc Revenue in Molecular Pharming Business (2020-2025)

11.1.5 Medicago Inc Recent Development

11.2 Meristem Therapeutics S.A. (Ventria Bioscience)

11.2.1 Meristem Therapeutics S.A. (Ventria Bioscience) Company Details

11.2.2 Meristem Therapeutics S.A. (Ventria Bioscience) Business Overview

11.2.3 Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Introduction

11.2.4 Meristem Therapeutics S.A. (Ventria Bioscience) Revenue in Molecular Pharming Business (2020-2025)

11.2.5 Meristem Therapeutics S.A. (Ventria Bioscience) Recent Development

11.3 Miruku

11.3.1 Miruku Company Details

11.3.2 Miruku Business Overview

11.3.3 Miruku Molecular Pharming Introduction

11.3.4 Miruku Revenue in Molecular Pharming Business (2020-2025)

11.3.5 Miruku Recent Development

11.4 Moolec Science Limited

11.4.1 Moolec Science Limited Company Details

11.4.2 Moolec Science Limited Business Overview

11.4.3 Moolec Science Limited Molecular Pharming Introduction

11.4.4 Moolec Science Limited Revenue in Molecular Pharming Business (2020-2025)

11.4.5 Moolec Science Limited Recent Development

11.5 mozza

11.5.1 mozza Company Details

11.5.2 mozza Business Overview

11.5.3 mozza Molecular Pharming Introduction

11.5.4 mozza Revenue in Molecular Pharming Business (2020-2025)

11.5.5 mozza Recent Development

11.6 Nobell Foods

11.6.1 Nobell Foods Company Details

11.6.2 Nobell Foods Business Overview

11.6.3 Nobell Foods Molecular Pharming Introduction

11.6.4 Nobell Foods Revenue in Molecular Pharming Business (2020-2025)

11.6.5 Nobell Foods Recent Development

11.7 Agrenvec S.L

11.7.1 Agrenvec S.L Company Details

11.7.2 Agrenvec S.L Business Overview

11.7.3 Agrenvec S.L Molecular Pharming Introduction

11.7.4 Agrenvec S.L Revenue in Molecular Pharming Business (2020-2025)

11.7.5 Agrenvec S.L Recent Development

11.8 Bright Biotech

11.8.1 Bright Biotech Company Details

11.8.2 Bright Biotech Business Overview

11.8.3 Bright Biotech Molecular Pharming Introduction

11.8.4 Bright Biotech Revenue in Molecular Pharming Business (2020-2025)

11.8.5 Bright Biotech Recent Development

11.9 Core Biogenesis

11.9.1 Core Biogenesis Company Details

11.9.2 Core Biogenesis Business Overview

11.9.3 Core Biogenesis Molecular Pharming Introduction

11.9.4 Core Biogenesis Revenue in Molecular Pharming Business (2020-2025)

11.9.5 Core Biogenesis Recent Development

11.10 Diamante SRL

11.10.1 Diamante SRL Company Details

11.10.2 Diamante SRL Business Overview

11.10.3 Diamante SRL Molecular Pharming Introduction

11.10.4 Diamante SRL Revenue in Molecular Pharming Business (2020-2025)

11.10.5 Diamante SRL Recent Development

11.11 Leaf Systems International Limited

11.11.1 Leaf Systems International Limited Company Details

11.11.2 Leaf Systems International Limited Business Overview

11.11.3 Leaf Systems International Limited Molecular Pharming Introduction

11.11.4 Leaf Systems International Limited Revenue in Molecular Pharming Business (2020-2025)

11.11.5 Leaf Systems International Limited Recent Development

11.12 ORF Genetics

11.12.1 ORF Genetics Company Details

11.12.2 ORF Genetics Business Overview

11.12.3 ORF Genetics Molecular Pharming Introduction

11.12.4 ORF Genetics Revenue in Molecular Pharming Business (2020-2025)

11.12.5 ORF Genetics Recent Development

11.13 Pfizer, Inc.

11.13.1 Pfizer, Inc. Company Details

11.13.2 Pfizer, Inc. Business Overview

11.13.3 Pfizer, Inc. Molecular Pharming Introduction

11.13.4 Pfizer, Inc. Revenue in Molecular Pharming Business (2020-2025)

11.13.5 Pfizer, Inc. Recent Development

11.14 ProdiGene Inc

11.14.1 ProdiGene Inc Company Details

11.14.2 ProdiGene Inc Business Overview

11.14.3 ProdiGene Inc Molecular Pharming Introduction

11.14.4 ProdiGene Inc Revenue in Molecular Pharming Business (2020-2025)

11.14.5 ProdiGene Inc Recent Development

11.15 Protalix Biotherapeutics, Inc

11.15.1 Protalix Biotherapeutics, Inc Company Details

11.15.2 Protalix Biotherapeutics, Inc Business Overview

11.15.3 Protalix Biotherapeutics, Inc Molecular Pharming Introduction

11.15.4 Protalix Biotherapeutics, Inc Revenue in Molecular Pharming Business (2020-2025)

11.15.5 Protalix Biotherapeutics, Inc Recent Development

11.16 Tiamat Sciences

11.16.1 Tiamat Sciences Company Details

11.16.2 Tiamat Sciences Business Overview

11.16.3 Tiamat Sciences Molecular Pharming Introduction

11.16.4 Tiamat Sciences Revenue in Molecular Pharming Business (2020-2025)

11.16.5 Tiamat Sciences Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Medicago

Miruku

Mozza

Nobell Foods

Agrenvec

Bright Biotech

Diamante

ORF Genetics

Pfizer Inc

Protalix BioTherapeutics, Inc.

Tiamat Sciences

Meristem Therapeutics S.A. (Ventria Bioscience)

Moolec Science Limited

Core Biogenesis

Leaf Systems International Limited

ProdiGene Inc

List of Tables

Table 1. Global Molecular Pharming Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Gene Gun

Table 3. Key Players of Agroinfiltration

Table 4. Key Players of Electroporation

Table 5. Key Players of Agrobacterium-Mediated Gene Transfer

Table 6. Global Molecular Pharming Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Molecular Pharming Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Molecular Pharming Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Molecular Pharming Market Share by Region (2020-2025)

Table 10. Global Molecular Pharming Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Molecular Pharming Market Share by Region (2026-2031)

Table 12. Molecular Pharming Market Trends

Table 13. Molecular Pharming Market Drivers

Table 14. Molecular Pharming Market Challenges

Table 15. Molecular Pharming Market Restraints

Table 16. Global Molecular Pharming Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Molecular Pharming Market Share by Players (2020-2025)

Table 18. Global Top Molecular Pharming Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Pharming as of 2024)

Table 19. Ranking of Global Top Molecular Pharming Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Molecular Pharming Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Molecular Pharming, Headquarters and Area Served

Table 22. Global Key Players of Molecular Pharming, Product and Application

Table 23. Global Key Players of Molecular Pharming, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Molecular Pharming Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Molecular Pharming Revenue Market Share by Type (2020-2025)

Table 27. Global Molecular Pharming Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Molecular Pharming Revenue Market Share by Type (2026-2031)

Table 29. Global Molecular Pharming Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Molecular Pharming Revenue Market Share by Application (2020-2025)

Table 31. Global Molecular Pharming Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Molecular Pharming Revenue Market Share by Application (2026-2031)

Table 33. North America Molecular Pharming Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Molecular Pharming Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Molecular Pharming Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Molecular Pharming Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Molecular Pharming Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Molecular Pharming Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Molecular Pharming Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Molecular Pharming Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Molecular Pharming Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Molecular Pharming Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Molecular Pharming Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Molecular Pharming Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Molecular Pharming Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Molecular Pharming Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Molecular Pharming Market Size by Country (2026-2031) & (US$ Million)

Table 48. Medicago Inc Company Details

Table 49. Medicago Inc Business Overview

Table 50. Medicago Inc Molecular Pharming Product

Table 51. Medicago Inc Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)

Table 52. Medicago Inc Recent Development

Table 53. Meristem Therapeutics S.A. (Ventria Bioscience) Company Details

Table 54. Meristem Therapeutics S.A. (Ventria Bioscience) Business Overview

Table 55. Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Product

Table 56. Meristem Therapeutics S.A. (Ventria Bioscience) Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)

Table 57. Meristem Therapeutics S.A. (Ventria Bioscience) Recent Development

Table 58. Miruku Company Details

Table 59. Miruku Business Overview

Table 60. Miruku Molecular Pharming Product

Table 61. Miruku Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)

Table 62. Miruku Recent Development

Table 63. Moolec Science Limited Company Details

Table 64. Moolec Science Limited Business Overview

Table 65. Moolec Science Limited Molecular Pharming Product

Table 66. Moolec Science Limited Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)

Table 67. Moolec Science Limited Recent Development

Table 68. mozza Company Details

Table 69. mozza Business Overview

Table 70. mozza Molecular Pharming Product

Table 71. mozza Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)

Table 72. mozza Recent Development

Table 73. Nobell Foods Company Details

Table 74. Nobell Foods Business Overview

Table 75. Nobell Foods Molecular Pharming Product

Table 76. Nobell Foods Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)

Table 77. Nobell Foods Recent Development

Table 78. Agrenvec S.L Company Details

Table 79. Agrenvec S.L Business Overview

Table 80. Agrenvec S.L Molecular Pharming Product

Table 81. Agrenvec S.L Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)

Table 82. Agrenvec S.L Recent Development

Table 83. Bright Biotech Company Details

Table 84. Bright Biotech Business Overview

Table 85. Bright Biotech Molecular Pharming Product

Table 86. Bright Biotech Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)

Table 87. Bright Biotech Recent Development

Table 88. Core Biogenesis Company Details

Table 89. Core Biogenesis Business Overview

Table 90. Core Biogenesis Molecular Pharming Product

Table 91. Core Biogenesis Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)

Table 92. Core Biogenesis Recent Development

Table 93. Diamante SRL Company Details

Table 94. Diamante SRL Business Overview

Table 95. Diamante SRL Molecular Pharming Product

Table 96. Diamante SRL Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)

Table 97. Diamante SRL Recent Development

Table 98. Leaf Systems International Limited Company Details

Table 99. Leaf Systems International Limited Business Overview

Table 100. Leaf Systems International Limited Molecular Pharming Product

Table 101. Leaf Systems International Limited Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)

Table 102. Leaf Systems International Limited Recent Development

Table 103. ORF Genetics Company Details

Table 104. ORF Genetics Business Overview

Table 105. ORF Genetics Molecular Pharming Product

Table 106. ORF Genetics Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)

Table 107. ORF Genetics Recent Development

Table 108. Pfizer, Inc. Company Details

Table 109. Pfizer, Inc. Business Overview

Table 110. Pfizer, Inc. Molecular Pharming Product

Table 111. Pfizer, Inc. Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)

Table 112. Pfizer, Inc. Recent Development

Table 113. ProdiGene Inc Company Details

Table 114. ProdiGene Inc Business Overview

Table 115. ProdiGene Inc Molecular Pharming Product

Table 116. ProdiGene Inc Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)

Table 117. ProdiGene Inc Recent Development

Table 118. Protalix Biotherapeutics, Inc Company Details

Table 119. Protalix Biotherapeutics, Inc Business Overview

Table 120. Protalix Biotherapeutics, Inc Molecular Pharming Product

Table 121. Protalix Biotherapeutics, Inc Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)

Table 122. Protalix Biotherapeutics, Inc Recent Development

Table 123. Tiamat Sciences Company Details

Table 124. Tiamat Sciences Business Overview

Table 125. Tiamat Sciences Molecular Pharming Product

Table 126. Tiamat Sciences Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)

Table 127. Tiamat Sciences Recent Development

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Molecular Pharming Picture

Figure 2. Global Molecular Pharming Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Molecular Pharming Market Share by Type: 2024 VS 2031

Figure 4. Gene Gun Features

Figure 5. Agroinfiltration Features

Figure 6. Electroporation Features

Figure 7. Agrobacterium-Mediated Gene Transfer Features

Figure 8. Global Molecular Pharming Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Molecular Pharming Market Share by Application: 2024 VS 2031

Figure 10. Recombinant Antibodies Case Studies

Figure 11. Hormones, Vaccines Case Studies

Figure 12. Industrial Enzymes Case Studies

Figure 13. Proteins & Protein-Based Materials Case Studies

Figure 14. Technical Reagents Case Studies

Figure 15. Nutritional Products Case Studies

Figure 16. Molecular Pharming Report Years Considered

Figure 17. Global Molecular Pharming Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Molecular Pharming Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Molecular Pharming Market Share by Region: 2024 VS 2031

Figure 20. Global Molecular Pharming Market Share by Players in 2024

Figure 21. Global Top Molecular Pharming Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Pharming as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Molecular Pharming Revenue in 2024

Figure 23. North America Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Molecular Pharming Market Share by Country (2020-2031)

Figure 25. United States Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Molecular Pharming Market Share by Country (2020-2031)

Figure 29. Germany Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Molecular Pharming Market Share by Region (2020-2031)

Figure 37. China Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Molecular Pharming Market Share by Country (2020-2031)

Figure 45. Mexico Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Molecular Pharming Market Share by Country (2020-2031)

Figure 49. Turkey Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Medicago Inc Revenue Growth Rate in Molecular Pharming Business (2020-2025)

Figure 53. Meristem Therapeutics S.A. (Ventria Bioscience) Revenue Growth Rate in Molecular Pharming Business (2020-2025)

Figure 54. Miruku Revenue Growth Rate in Molecular Pharming Business (2020-2025)

Figure 55. Moolec Science Limited Revenue Growth Rate in Molecular Pharming Business (2020-2025)

Figure 56. mozza Revenue Growth Rate in Molecular Pharming Business (2020-2025)

Figure 57. Nobell Foods Revenue Growth Rate in Molecular Pharming Business (2020-2025)

Figure 58. Agrenvec S.L Revenue Growth Rate in Molecular Pharming Business (2020-2025)

Figure 59. Bright Biotech Revenue Growth Rate in Molecular Pharming Business (2020-2025)

Figure 60. Core Biogenesis Revenue Growth Rate in Molecular Pharming Business (2020-2025)

Figure 61. Diamante SRL Revenue Growth Rate in Molecular Pharming Business (2020-2025)

Figure 62. Leaf Systems International Limited Revenue Growth Rate in Molecular Pharming Business (2020-2025)

Figure 63. ORF Genetics Revenue Growth Rate in Molecular Pharming Business (2020-2025)

Figure 64. Pfizer, Inc. Revenue Growth Rate in Molecular Pharming Business (2020-2025)

Figure 65. ProdiGene Inc Revenue Growth Rate in Molecular Pharming Business (2020-2025)

Figure 66. Protalix Biotherapeutics, Inc Revenue Growth Rate in Molecular Pharming Business (2020-2025)

Figure 67. Tiamat Sciences Revenue Growth Rate in Molecular Pharming Business (2020-2025)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Molecular Plant Agriculture Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Molecular Farming Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Molecular Targeted Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Genetically Modified Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Molecular Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Molecular Biology Software Modules Market Research Report 2024

Global Biomolecule Software Market Research Report 2024

Global Molecular Biology Service Market Research Report 2025

Global Molecular Methods Market Insights Forecast to 2030

Small Molecule Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Membrane Technology in Pharma Biopharma And Life Science Market

CRM in Pharma and Biotech Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Bioprocess Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Digital Biomanufacturing Market Insights Forecast to 2030

Genetically Modified GMO Seeds Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Viral Molecular Diagnostics Market Research Report 2024

Global Molecular Diagnosis and Therapy Market Insights Forecast to 2030

Molecular Diagnostic Reagent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Intelligent Drug R D Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions